Services That Plug Into Your Operating Model
Five practice areas, delivered by leads who have shipped inspection-ready systems in FDA, EMA, MHRA, PMDA and CDSCO environments.
Cybroscape delivers five practice areas for regulated life sciences: validation and compliance, clinical services, regulatory services, AI transformation, and managed services. Engagements run with or without our software, and are delivered by leads who have shipped inspection-ready systems in FDA, EMA, MHRA, PMDA and CDSCO environments.
Validation & Compliance Services
Explore →Clinical Services
Explore →Regulatory Services
Explore →AI Transformation
Explore →Managed Services
Explore →Which practice you need depends on the situation, not the system
Validation work arrives in one of a few recognisable situations, and the right scope differs sharply between them. A new system going live needs a full lifecycle. An inspection finding needs targeted remediation and evidence you can produce quickly. A vendor upgrade that broke validated status needs an impact assessment before anything else. An estate inherited through acquisition needs triage.
Quoting a package before establishing which of these you are in is how validation engagements end up scoped to the vendor's template rather than to your problem. We ask first.
A full lifecycle: requirements, risk assessment, IQ, OQ and PQ sized to risk, traceability and a summary report, finished before the go-live date.
Services with the products, or without them
Every engagement runs either way. Where GxP Copilot or TraceDraft is used, it compresses the document assembly that normally dominates the schedule, which usually shortens the timeline. The deliverables and the regulatory standard are identical either way.
We would rather you saw the scope first and decided about tooling second. A services engagement that only works if you also adopt a platform is a sales motion rather than a delivery model.
Our leads deliver the package with your tools and templates.
The products compress document assembly, so the same team ships faster.
Built for teams without a validation department
Regulation does not scale with company size. A Series B biotech deploying a LIMS faces the same Annex 11 and Part 11 expectations as a top-twenty manufacturer deploying the same product — without a dedicated validation function, established templates, or a QA team that has seen fifty of these.
That gap is the one this practice exists to close. The judgement calls stay with your quality lead; what we remove is the assembly burden and the uncertainty about what the scope should actually be.
What happens after go-live
Getting a system validated is a project with a budget and a finish line. Keeping it validated is nobody's project, which is why most estates drift — overdue periodic reviews, changes processed outside change control, traceability that stopped matching the system months ago.
Periodic review
A review cadence that keeps systems in their validated state.
ScheduledChange control support
Every change assessed for its impact on validated status.
On demandSupplier reassessment
Vendor evidence refreshed when suppliers change.
Annual or on changeOur managed services cover the lifecycle obligations that have no project attached: periodic review cadence, change control support, supplier reassessment and revalidation execution. More on the cost of skipping them in validation debt.
Common questions
Prefer to talk first? Chat with us on WhatsApp or book a call with an expert.
What services does Cybroscape provide?
Five practice areas: validation and compliance (CSV, CSA, AI validation, equipment and instrument qualification, data integrity, audit readiness), clinical services (medical writing, CSR authoring, safety narratives, clinical operations), regulatory services (regulatory operations and intelligence, eQMS and RIM implementation, CAPA and pharmacovigilance programme design), AI transformation, and managed services.
Do we have to buy your software to use your services?
No. Every engagement runs with or without GxP Copilot and TraceDraft. The products compress the document assembly, which usually shortens the timeline and reduces the cost, but the deliverables are the same either way and the choice is yours to make after seeing the scope.
How do engagements usually start?
With a scoping conversation about which situation you are in — a new system going live, an inspection finding, a vendor upgrade that broke validated status, an estate inherited through acquisition, or a capacity ceiling in clinical writing. The right scope looks materially different in each case, which is why we ask before quoting.
Do you work with mid-market companies, or only large manufacturers?
Mid-market is the segment we are built for. The regulatory obligation does not scale with company size, but the infrastructure for meeting it does, so a Series B biotech faces the same Annex 11 expectations without a validation department. That gap is the one our services practice exists to close.
Which regulatory environments do your leads work in?
FDA, EMA, MHRA, PMDA and CDSCO regulated environments, across pharmaceuticals, biotechnology, medical devices, CROs and diagnostics. Where a project spans both US and EU expectations we assess against both rather than assuming that satisfying one satisfies the other.
Tell us your situation. We will scope it honestly.
A validation lead reviews your system and timeline, then proposes the smallest scope that will pass inspection.
- We reply within one business day
- We look at your system before we quote
- You get a clear plan for your situation